Bank of New York Mellon Corp boosted its holdings in shares of Envision Healthcare Co. (NYSE:EVHC) by 1.1% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 943,331 shares of the company’s stock after acquiring an additional 10,195 shares during the period. Bank of New York Mellon Corp owned about 0.78% of Envision Healthcare worth $42,403,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors have also modified their holdings of the company. ING Groep NV boosted its holdings in shares of Envision Healthcare by 0.3% in the 2nd quarter. ING Groep NV now owns 6,022 shares of the company’s stock valued at $377,000 after buying an additional 21 shares in the last quarter. CIBC Asset Management Inc boosted its holdings in shares of Envision Healthcare by 0.4% in the 2nd quarter. CIBC Asset Management Inc now owns 10,078 shares of the company’s stock valued at $632,000 after buying an additional 38 shares in the last quarter. Sawtooth Solutions LLC boosted its holdings in shares of Envision Healthcare by 0.7% in the 2nd quarter. Sawtooth Solutions LLC now owns 6,656 shares of the company’s stock valued at $417,000 after buying an additional 43 shares in the last quarter. Boys Arnold & Co. Inc. boosted its holdings in shares of Envision Healthcare by 0.6% in the 2nd quarter. Boys Arnold & Co. Inc. now owns 8,125 shares of the company’s stock valued at $509,000 after buying an additional 50 shares in the last quarter. Finally, PNC Financial Services Group Inc. boosted its holdings in shares of Envision Healthcare by 1.5% in the 2nd quarter. PNC Financial Services Group Inc. now owns 4,848 shares of the company’s stock valued at $304,000 after buying an additional 70 shares in the last quarter.

Envision Healthcare Co. (EVHC) traded up $0.40 during mid-day trading on Wednesday, reaching $31.23. 2,627,000 shares of the company were exchanged, compared to its average volume of 2,237,490. The firm has a market cap of $3,727.02, a PE ratio of 9.52, a PEG ratio of 0.80 and a beta of 0.57. The company has a quick ratio of 3.00, a current ratio of 3.01 and a debt-to-equity ratio of 0.89. Envision Healthcare Co. has a one year low of $23.77 and a one year high of $74.19.

Envision Healthcare (NYSE:EVHC) last released its earnings results on Tuesday, October 31st. The company reported $0.73 EPS for the quarter, missing analysts’ consensus estimates of $0.81 by ($0.08). The company had revenue of $1.99 billion during the quarter, compared to analyst estimates of $2.03 billion. Envision Healthcare had a positive return on equity of 4.88% and a negative net margin of 6.39%. The firm’s revenue for the quarter was up 142.0% on a year-over-year basis. During the same quarter last year, the business earned $1.13 earnings per share. sell-side analysts anticipate that Envision Healthcare Co. will post 2.57 earnings per share for the current year.

Envision Healthcare announced that its board has approved a share repurchase program on Monday, September 18th that authorizes the company to repurchase $250.00 million in shares. This repurchase authorization authorizes the company to repurchase up to 4.5% of its stock through open market purchases. Stock repurchase programs are generally a sign that the company’s leadership believes its shares are undervalued.

EVHC has been the topic of a number of recent analyst reports. Robert W. Baird restated a “buy” rating and issued a $70.00 price target on shares of Envision Healthcare in a report on Tuesday, October 17th. SunTrust Banks set a $55.00 price target on shares of Envision Healthcare and gave the company a “buy” rating in a report on Sunday, October 15th. Bank of America lowered their price target on shares of Envision Healthcare from $72.00 to $60.00 and set a “buy” rating on the stock in a report on Monday, October 9th. Jefferies Group set a $71.00 price target on shares of Envision Healthcare and gave the company a “buy” rating in a report on Thursday, August 24th. Finally, KeyCorp set a $67.00 price target on shares of Envision Healthcare and gave the company a “buy” rating in a report on Wednesday, November 1st. One equities research analyst has rated the stock with a sell rating, six have given a hold rating, ten have issued a buy rating and one has assigned a strong buy rating to the company. The stock currently has a consensus rating of “Buy” and a consensus price target of $47.57.

COPYRIGHT VIOLATION WARNING: “Bank of New York Mellon Corp Acquires 10,195 Shares of Envision Healthcare Co. (EVHC)” was reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this piece of content on another publication, it was illegally stolen and reposted in violation of US & international copyright law. The correct version of this piece of content can be viewed at https://www.thecerbatgem.com/2017/12/06/bank-of-new-york-mellon-corp-acquires-10195-shares-of-envision-healthcare-co-evhc.html.

Envision Healthcare Profile

Envision Healthcare Holdings, Inc, formerly CDRT Holding Corporation, is a holding company. The Company, through its subsidiary, provides physician-led medical services in the United States. It operates in two segments: EmCare Holdings, Inc (EmCare) and American Medical Response, Inc (AMR). Its EmCare segment is a provider of integrated facility-based and post-acute care physician services to healthcare facilities in the United States.

Institutional Ownership by Quarter for Envision Healthcare (NYSE:EVHC)

Receive News & Stock Ratings for Envision Healthcare Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envision Healthcare Co. and related stocks with our FREE daily email newsletter.